Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: Lessons learned from GELIA (GELIA 5)

European Heart Journal, Supplement

Volumn 3, Issue Q, 2001, Pages

  Pruefer, Diethard ^a   Dahm, M ^a   Dohmen, G ^a   Horstkotte, D ^b   Bergemann, R ^c   Oelert, H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Institute for Medical Outcome Research (IMOR)   (Germany)

Author keywords

Anticoagulant regimen; Bleeding; Heart valve prosthesis; Survival rate; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GERMANY; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPLACEMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAINT JUDE HEART VALVE PROSTHESIS; SURVIVAL RATE; THROMBOEMBOLISM; THROMBOSIS; TREATMENT PLANNING;

EID: 0035664713     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(01)90041-0     Document Type: Article

References (15)

1. Hemorrhagic complications of anticoagulant treatment
2. Mitral valve replacement with St. Jude Medical prosthesis and low-dose anticoagulation in patients aged over 50 years
3. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical Prostheses
4. St. Jude Medical prosthesis: Valve-related deaths and complications
5. St. Jude prosthesis for aortic and mitral valve replacement: A ten year experience
6. The St. Jude Medical valve: Experience in 1000 cases
7. Long term experience with the St. Jude Medical valve prosthesis
8. German Experience with Low Intensity Anticoagulation (GELIA): Protocol of a multi-center randomized prospective study with the St. Jude Medical valve
9. Long-term follow up after heart valve replacement
10. Guidelines for prevention of thromboembolic events in valvular heart disease
11. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves
12. Optimization of oral anticoagulation for patients with mechanical heart valve prostheses
13. Guidelines for the management of patients with valvular heart disease: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
14. Potential flaws in the assessment of minor cerebrovascular events after heart valve replacement